Duane A. Burnett

Ark Therapeutic (United States) US

0000-0002-1444-7802

148

Publications

4,215

Citations

H-Index

i10-Index

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

148 total

The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)

Margarita García‐Calvo, JeanMarie Lisnock, Herbert G. Bull, Brian E. Hawes, Duane A. Burnett et al. - Proceedings of the National Academy of Sciences, 2005

Cited by 765 OpenAlex

&#946;-Lactam Cholesterol Absorption Inhibitors

Duane A. Burnett - Current Medicinal Chemistry, 2004

Cited by 137 OpenAlex

The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption

S. Altmann, Harry R. Davis, Xiaorui Yao, Maureen Laverty, Douglas S. Compton et al. - Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2002

Cited by 160 OpenAlex

Discovery of 1-(4-Fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)- hydroxypropyl]-(4S)-(4-hydroxyphenyl)-2-azetidinone (SCH 58235): A Designed, Potent, Orally Active Inhibitor of Cholesterol Absorption

Stuart B. Rosenblum, Tram Huynh, Adriano Afonso, Harry R. Davis, Nathan Yumibe et al. - Journal of Medicinal Chemistry, 1998

Cited by 353 OpenAlex

2-Azetidinones as Inhibitors of Cholesterol Absorption PDF

Duane A. Burnett, Mary Ann Caplen, Harry R. Davis, Robert E. Burrier, John W. Clader - Journal of Medicinal Chemistry, 1994

Cited by 238 OpenAlex

Pyrrolizidinone and indolizidinone synthesis: generation and intramolecular addition of .alpha.-acylamino radicals to olefins and allenes

Duane A. Burnett, Joong Kwon Choi, David J. Hart, Y.‐M. TSAI - Journal of the American Chemical Society, 1984

Cited by 146 OpenAlex

Research Topics

Synthesis of β-Lactam Compounds (16) Synthesis and Catalytic Reactions (13) Receptor Mechanisms and Signaling (12) Cholinesterase and Neurodegenerative Diseases (12) Alzheimer's disease research and treatments (8)

Affiliations

University of London

GB 1965 - 1965

Merck & Co., Inc., Rahway, NJ, USA (United States)

US 2016 - 2005

Birmingham City University

GB 1985 - 1985

Cheltenham General Hospital

GB 1995 - 1995

University of California, San Francisco

US 1979 - 1979

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers

Duane A. Burnett

Publication & Citation Trends

Publications

The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)

&amp;#946;-Lactam Cholesterol Absorption Inhibitors

The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption

Discovery of 1-(4-Fluorophenyl)-(3<i>R</i>)-[3-(4-fluorophenyl)-(3<i>S</i>)- hydroxypropyl]-(4<i>S</i>)-(4-hydroxyphenyl)-2-azetidinone (SCH 58235): A Designed, Potent, Orally Active Inhibitor of Cholesterol Absorption

2-Azetidinones as Inhibitors of Cholesterol Absorption PDF

Pyrrolizidinone and indolizidinone synthesis: generation and intramolecular addition of .alpha.-acylamino radicals to olefins and allenes

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back

β-Lactam Cholesterol Absorption Inhibitors